α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation

Nilum Rajora, Giovanni Boccoli, Dennis Burns, Sarita Sharma, Anna P. Catania, James M. Lipton

Research output: Contribution to journalArticle

Abstract

Tumor necrosis factor (TNF-α) underlies pathological processes and functional disturbances in acute and chronic neurological disease and injury. The neuroimmunomodulatory peptide α-MSH modulates actions and production of proinflammatory cytokines including TNF-α, but there is no prior evidence that it alters TNF-α induced within the brain. To test for this potential influence of the peptide, TNP-α was induced centrally by local injection of bacterial lipopolysaccharide (LPS). α-MSH given once i.c.v. with LPS challenge, twice daily intraperitoneally (i.p.) for 5 d between central LPS injections, or both i.p. and centrally, inhibited production of TNF-α within brain tissue. Inhibition of TNF-α protein formation by α-MSH was confirmed by inhibition of TNF-α mRNA. Plasma TNF-α concentration was elevated markedly after central LPS, indicative of an augmented peripheral host response induced by the CNS signal. The increase was inhibited by α-MSH treatments, in relation to inhibition of central TNF-α. Presence within normal mouse brain of mRNA for the α-MSH receptor MC-1 suggests that the inhibitory effects of α-MSH on brain and plasma TNF-α might be mediated by this receptor subtype. The inhibitory effect of α-MSH on brain TNF-α did not depend on circulating factors because the effect also occurred in brain tissue in vitro. This indicates that α-MSH can act directly on brain cells to inhibit their production of TNF-α. If central TNF-α contributes to pathology in CNS disease and injury, and promotes inflammation in the periphery, agents that act on brain α-MSH receptors should decrease the pathological TNF-α reaction and promote tissue survival.

Original languageEnglish
Pages (from-to)2181-2186
Number of pages6
JournalJournal of Neuroscience
Volume17
Issue number6
Publication statusPublished - Mar 15 1997

Fingerprint

Melanocyte-Stimulating Hormones
Encephalitis
Tumor Necrosis Factor-alpha
Brain
Lipopolysaccharides
Tissue Survival
Messenger RNA
Peptides
Injections
Central Nervous System Diseases
Wounds and Injuries
Pathologic Processes

Keywords

  • α-MSH
  • anti-inflammatory
  • anticytokine
  • LPS
  • modulation of CNS inflammation
  • neurodegenerative disease
  • neuroimmunomodulation
  • TNF-α

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rajora, N., Boccoli, G., Burns, D., Sharma, S., Catania, A. P., & Lipton, J. M. (1997). α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. Journal of Neuroscience, 17(6), 2181-2186.

α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. / Rajora, Nilum; Boccoli, Giovanni; Burns, Dennis; Sharma, Sarita; Catania, Anna P.; Lipton, James M.

In: Journal of Neuroscience, Vol. 17, No. 6, 15.03.1997, p. 2181-2186.

Research output: Contribution to journalArticle

Rajora, N, Boccoli, G, Burns, D, Sharma, S, Catania, AP & Lipton, JM 1997, 'α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation', Journal of Neuroscience, vol. 17, no. 6, pp. 2181-2186.
Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM. α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. Journal of Neuroscience. 1997 Mar 15;17(6):2181-2186.
Rajora, Nilum ; Boccoli, Giovanni ; Burns, Dennis ; Sharma, Sarita ; Catania, Anna P. ; Lipton, James M. / α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. In: Journal of Neuroscience. 1997 ; Vol. 17, No. 6. pp. 2181-2186.
@article{c76eaed82e4149ee85dd3a5d8fd50fa5,
title = "α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation",
abstract = "Tumor necrosis factor (TNF-α) underlies pathological processes and functional disturbances in acute and chronic neurological disease and injury. The neuroimmunomodulatory peptide α-MSH modulates actions and production of proinflammatory cytokines including TNF-α, but there is no prior evidence that it alters TNF-α induced within the brain. To test for this potential influence of the peptide, TNP-α was induced centrally by local injection of bacterial lipopolysaccharide (LPS). α-MSH given once i.c.v. with LPS challenge, twice daily intraperitoneally (i.p.) for 5 d between central LPS injections, or both i.p. and centrally, inhibited production of TNF-α within brain tissue. Inhibition of TNF-α protein formation by α-MSH was confirmed by inhibition of TNF-α mRNA. Plasma TNF-α concentration was elevated markedly after central LPS, indicative of an augmented peripheral host response induced by the CNS signal. The increase was inhibited by α-MSH treatments, in relation to inhibition of central TNF-α. Presence within normal mouse brain of mRNA for the α-MSH receptor MC-1 suggests that the inhibitory effects of α-MSH on brain and plasma TNF-α might be mediated by this receptor subtype. The inhibitory effect of α-MSH on brain TNF-α did not depend on circulating factors because the effect also occurred in brain tissue in vitro. This indicates that α-MSH can act directly on brain cells to inhibit their production of TNF-α. If central TNF-α contributes to pathology in CNS disease and injury, and promotes inflammation in the periphery, agents that act on brain α-MSH receptors should decrease the pathological TNF-α reaction and promote tissue survival.",
keywords = "α-MSH, anti-inflammatory, anticytokine, LPS, modulation of CNS inflammation, neurodegenerative disease, neuroimmunomodulation, TNF-α",
author = "Nilum Rajora and Giovanni Boccoli and Dennis Burns and Sarita Sharma and Catania, {Anna P.} and Lipton, {James M.}",
year = "1997",
month = "3",
day = "15",
language = "English",
volume = "17",
pages = "2181--2186",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "6",

}

TY - JOUR

T1 - α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation

AU - Rajora, Nilum

AU - Boccoli, Giovanni

AU - Burns, Dennis

AU - Sharma, Sarita

AU - Catania, Anna P.

AU - Lipton, James M.

PY - 1997/3/15

Y1 - 1997/3/15

N2 - Tumor necrosis factor (TNF-α) underlies pathological processes and functional disturbances in acute and chronic neurological disease and injury. The neuroimmunomodulatory peptide α-MSH modulates actions and production of proinflammatory cytokines including TNF-α, but there is no prior evidence that it alters TNF-α induced within the brain. To test for this potential influence of the peptide, TNP-α was induced centrally by local injection of bacterial lipopolysaccharide (LPS). α-MSH given once i.c.v. with LPS challenge, twice daily intraperitoneally (i.p.) for 5 d between central LPS injections, or both i.p. and centrally, inhibited production of TNF-α within brain tissue. Inhibition of TNF-α protein formation by α-MSH was confirmed by inhibition of TNF-α mRNA. Plasma TNF-α concentration was elevated markedly after central LPS, indicative of an augmented peripheral host response induced by the CNS signal. The increase was inhibited by α-MSH treatments, in relation to inhibition of central TNF-α. Presence within normal mouse brain of mRNA for the α-MSH receptor MC-1 suggests that the inhibitory effects of α-MSH on brain and plasma TNF-α might be mediated by this receptor subtype. The inhibitory effect of α-MSH on brain TNF-α did not depend on circulating factors because the effect also occurred in brain tissue in vitro. This indicates that α-MSH can act directly on brain cells to inhibit their production of TNF-α. If central TNF-α contributes to pathology in CNS disease and injury, and promotes inflammation in the periphery, agents that act on brain α-MSH receptors should decrease the pathological TNF-α reaction and promote tissue survival.

AB - Tumor necrosis factor (TNF-α) underlies pathological processes and functional disturbances in acute and chronic neurological disease and injury. The neuroimmunomodulatory peptide α-MSH modulates actions and production of proinflammatory cytokines including TNF-α, but there is no prior evidence that it alters TNF-α induced within the brain. To test for this potential influence of the peptide, TNP-α was induced centrally by local injection of bacterial lipopolysaccharide (LPS). α-MSH given once i.c.v. with LPS challenge, twice daily intraperitoneally (i.p.) for 5 d between central LPS injections, or both i.p. and centrally, inhibited production of TNF-α within brain tissue. Inhibition of TNF-α protein formation by α-MSH was confirmed by inhibition of TNF-α mRNA. Plasma TNF-α concentration was elevated markedly after central LPS, indicative of an augmented peripheral host response induced by the CNS signal. The increase was inhibited by α-MSH treatments, in relation to inhibition of central TNF-α. Presence within normal mouse brain of mRNA for the α-MSH receptor MC-1 suggests that the inhibitory effects of α-MSH on brain and plasma TNF-α might be mediated by this receptor subtype. The inhibitory effect of α-MSH on brain TNF-α did not depend on circulating factors because the effect also occurred in brain tissue in vitro. This indicates that α-MSH can act directly on brain cells to inhibit their production of TNF-α. If central TNF-α contributes to pathology in CNS disease and injury, and promotes inflammation in the periphery, agents that act on brain α-MSH receptors should decrease the pathological TNF-α reaction and promote tissue survival.

KW - α-MSH

KW - anti-inflammatory

KW - anticytokine

KW - LPS

KW - modulation of CNS inflammation

KW - neurodegenerative disease

KW - neuroimmunomodulation

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=0031029193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031029193&partnerID=8YFLogxK

M3 - Article

C2 - 9045742

AN - SCOPUS:0031029193

VL - 17

SP - 2181

EP - 2186

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 6

ER -